miR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 8565-8572

  Wang, Guangzhi ^a   Zhao, Yan ^a   Zheng, Yongri ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Glioma; miR 122; Wnt catenin

Indexed keywords

ADENOVIRUS VECTOR; BETA CATENIN; HEPATOCYTE NUCLEAR FACTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MICRORNA 122; WNT PROTEIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MICRORNA; MIRN122 MICRORNA, HUMAN; WNT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CANCER SURVIVAL; CARCINOGENICITY; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; MTT ASSAY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HEK293 CELL LINE; IMMUNOBLOTTING; LUMINESCENCE; METABOLISM; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MODELS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84919835266     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2089-4     Document Type: Article

References (22)

1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.
2. Meister G. miRNAs get an early start on translational silencing. Cell. 2007;131(1):25–8.
3. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122(1):6–7.
4. Besse A, Sana J, Fadrus P, Slaby O. MicroRNAs involved in chemo- and radioresistance of high-grade gliomas. Tumour Biol. 2013;34(4):1969–78. doi:10.1007/s13277-013-0772-5.
5. Li M, Li J, Liu L, Li W, Yang Y, Yuan J. MicroRNA in human glioma. Cancers (Basel). 2013;5(4):1306–31.
6. Peng B, Hu S, Jun Q, Luo D, Zhang X, Zhao H, et al. MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma. Mol Cell Biochem. 2013;379(1–2):51–8. doi:10.1007/s11010-013-1626-6.
7. Filipowicz W, Grosshans H. The liver-specific microRNA miR-122: biology and therapeutic potential. Prog Drug Res. 2011;67:221–38.
8. Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y, et al. Overexpression of the transcription factor MEF2D in hepatocellular cancer sustains malignant character by suppressing G2/M transition genes. Cancer Res. 2014. doi:10.1158/0008-5472.CAN-13-2171.
9. Ma L, Liu J, Shen J, Liu L, Wu J, Li W, et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther. 2010;9(7):554–61.
10. Wang B, Wang H, Yang Z. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS One. 2012;7(10):e47053.
11. Kanaan Z, Rai SN, Eichenberger MR, Barnes C, Dworkin AM, Weller C, et al. Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat. 2012;33(3):551–60.
12. Kunte DP, DelaCruz M, Wali RK, Menon A, Du H, Stypula Y, et al. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening. PLoS One. 2012;7(9):e45591.
13. Qian J, Zhai A, Kao W, Li Y, Song W, Fu Y, et al. Modulation of miR-122 on persistently Borna disease virus infected human oligodendroglial cells. Antivir Res. 2010;87(2):249–56.
14. Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, et al. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52(4):1431–42. doi:10.1002/hep.23818.
15. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007;67(13):6092–9.
16. Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008;375(3):315–20.
17. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49(5):1571–82.
18. Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, et al. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology. 2010;52(5):1702–12.
19. Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012;32(5):752–60.
20. Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J et al. Reciprocal regulation of miR-122 and c-Myc in hepatocellular cancer: role of E2F1 and TFDP2. Hepatology. 2013.
21. Manfe V, Biskup E, Rosbjerg A, Kamstrup M, Skov AG, Lerche CM, et al. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One. 2012;7(1):e29541.
22. Lian JH, Wang WH, Wang JQ, Zhang YH, Li Y. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway. Asian Pac J Cancer Prev. 2013;14(9):5017–21.